Sefal Pharmaceutics Private Limited
About Sefal Pharmaceutics Private Limited
Data last updated:
Sefal Pharmaceutics Private Limited was a private limited company based in Dhuri, Punjab, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 March 1999.
The company was registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB1999PTC022320. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹15 Lakh and a paid-up capital of ₹14.5 Lakh. It was led by directors Shaheer Zaman Ariz and Yashpal Arora.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at 1 A 169 Janta Nagarm K Road Dhuri Distt Sangrur, Punjab, India – 148024.
As per the financials filed for FY 2019, the company reported a revenue of ₹36.76 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹6.65 Lakh (net margin -18.1%) and EBITDA of -₹6.55 Lakh (EBITDA margin -17.8%). Revenue has declined at a compounded annual rate (CAGR) of 42% over three years.
As per MCA filings, the company had satisfied charges of ₹8 Lakh on record.
Company details
Contact details
Sefal Pharmaceutics Private Limited's registered office is in Dhuri, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1 A 169 Janta Nagarm K Road Dhuri Distt Sangrur, Punjab, India – 148024
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sefal Pharmaceutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sefal Pharmaceutics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sefal Pharmaceutics Private Limited, buy the company report.
Financials of Sefal Pharmaceutics Private Limited
FY 2019 filings availableSefal Pharmaceutics Private Limited reported revenue of ₹36.76 Lakh (up 14609% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 42% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹36.76 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6.55 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.65 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -17.8% | ||||
| Net Profit Margin | -18.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sefal Pharmaceutics Private Limited, buy the company report.
Board of directors of Sefal Pharmaceutics Private Limited
Sefal Pharmaceutics has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shaheer Zaman Ariz | Director | 22 Sep 2014 | 12 Years 1 Months | As last reported |
| Yashpal Arora | Director | 22 Sep 2014 | 12 Years 1 Months | As last reported |
Peer comparison
Sefal Pharmaceutics Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cardion Biotech Private Limited | ₹36.81 Lakh (FY 2025) | 200.0% | Dehradun, Uttarakhand, India | |||
| Albacore Pharmaceutical Private Limited | ₹36.8 Lakh (FY 2025) | -55.0% | Mumbai, Maharashtra, India | |||
| Sefal Pharmaceutics Private Limitedthis company | ₹36.76 Lakh (FY 2019) | -₹6.65 Lakh | -18.1% | 14609.0% | Dhuri, Punjab, India | |
| Beactive Pharmaceuticals Private Limited | ₹36.65 Lakh (FY 2024) | 85.0% | Ambala, Haryana, India | |||
| Lumos Drugs & Surgical Private Limited | ₹36.56 Lakh (FY 2025) | 137.0% | Guwahati, Assam, India | |||
| Maars Formulations Private Limited | ₹36.53 Lakh (FY 2025) | 15.0% | New Delhi, Delhi, India |
To see the full peer comparison of Sefal Pharmaceutics Private Limited, buy the company report.
Auditor
Sefal Pharmaceutics Private Limited is audited by MANISH MANOCHA & COMPANY for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANISH MANOCHA & COMPANY | FY 2019 | 026892N |
Shareholding
The shareholding of Sefal Pharmaceutics Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Sefal Pharmaceutics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Oct 2002 | 90176069 | Punjab National Bank | ₹8 Lakh | Satisfied |
To see the full charge records of Sefal Pharmaceutics Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Sefal Pharmaceutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sefal Pharmaceutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sefal Pharmaceutics has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Sefal Pharmaceutics Private Limited, buy the company report.
Recent activity
Sefal Pharmaceutics Private Limited has 8 board changes on record since 2011: 2 appointments and 6 cessations. The latest: Hukam Chand Sharma ceased to be Director on 15 Oct 2014.
1 earlier event is in the company report.
Frequently asked questions
Sefal Pharmaceutics has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Sefal Pharmaceutics was a private limited company based in Dhuri, Punjab, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 March 1999 and is registered under CIN U24232PB1999PTC022320. The company has been struck off by the Registrar of Companies and is no longer operational.
Sefal Pharmaceutics had 2 directors:
- Shaheer Zaman Ariz - Director
- Yashpal Arora - Director
The CIN (Corporate Identification Number) of Sefal Pharmaceutics is U24232PB1999PTC022320. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Sefal Pharmaceutics is at 1 A 169 Janta Nagarm K Road Dhuri Distt Sangrur, Punjab, India – 148024.
Sefal Pharmaceutics was incorporated on 10 March 1999. It is registered with the Registrar of Companies, Chandigarh.
The latest financial statements of Sefal Pharmaceutics on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
No. Sefal Pharmaceutics has 1 GST registration on record and it is cancelled or inactive.
Sefal Pharmaceutics operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.
The peers of Sefal Pharmaceutics by revenue are Cardion Biotech Private Limited, Albacore Pharmaceutical Private Limited, Beactive Pharmaceuticals Private Limited, Lumos Drugs & Surgical Private Limited, Maars Formulations Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Hukam Chand Sharma ceased to be Director on 15 Oct 2014. Rajesh Kumar Sharma ceased to be Managing Director on 15 Oct 2014. Tarun Kumar Dawar ceased to be Director on 15 Oct 2014. Sefal Pharmaceutics has 8 board changes on record in total.